|
Volumn 239, Issue 1-2, 2002, Pages 37-46
|
Role of poly [DL-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s)
|
Author keywords
Antitubercular drugs; Oral drug delivery; PLG
|
Indexed keywords
ISONIAZID;
POLYGLACTIN;
PYRAZINAMIDE;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
ACIDITY;
ANIMAL EXPERIMENT;
ARTICLE;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG FORMULATION;
FEMALE;
IN VITRO STUDY;
INTESTINE FLUID;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
STOMACH JUICE;
SUSTAINED DRUG RELEASE;
TIME;
TUBERCULOSIS;
ADMINISTRATION, ORAL;
ANIMALS;
ANTIBIOTICS, ANTITUBERCULAR;
ANTITUBERCULAR AGENTS;
AREA UNDER CURVE;
BIOCOMPATIBLE MATERIALS;
CAPSULES;
DELAYED-ACTION PREPARATIONS;
DRUG COMPOUNDING;
FEMALE;
HALF-LIFE;
ISONIAZID;
LACTIC ACID;
MALE;
MICE;
PARTICLE SIZE;
POLYGLYCOLIC ACID;
POLYMERS;
PYRAZINAMIDE;
RIFAMPIN;
SOLUBILITY;
|
EID: 0037018964
PISSN: 03785173
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-5173(02)00034-0 Document Type: Article |
Times cited : (44)
|
References (16)
|